End-payors seek final approval of settlement with Impax in US antitrust case over Opana ER
MLex Summary: End-payor plaintiffs have asked a US federal judge to grant final approval to their $15 million settlement with Impax Laboratories to resolve claims that it engaged in an illegal...To view the full article, register now.
Already a subscriber? Click here to view full article